首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle
【2h】

Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle

机译:小锚蛋白1作为骨骼肌中的新型Sarco(内切)质网Ca2 + -ATPase 1(SERCA1)调节蛋白的鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Small ankyrin 1 (sAnk1) is a 17-kDa transmembrane (TM) protein that binds to the cytoskeletal protein, obscurin, and stabilizes the network sarcoplasmic reticulum in skeletal muscle. We report that sAnk1 shares homology in its TM amino acid sequence with sarcolipin, a small protein inhibitor of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA). Here we investigate whether sAnk1 and SERCA1 interact. Our results indicate that sAnk1 interacts specifically with SERCA1 in sarcoplasmic reticulum vesicles isolated from rabbit skeletal muscle, and in COS7 cells transfected to express these proteins. This interaction was demonstrated by co-immunoprecipitation and an anisotropy-based FRET method. Binding was reduced ∼2-fold by the replacement of all of the TM amino acids of sAnk1 with leucines by mutagenesis. This suggests that, like sarcolipin, sAnk1 interacts with SERCA1 at least in part via its TM domain. Binding of the cytoplasmic domain of sAnk1 to SERCA1 was also detected in vitro. ATPase activity assays show that co-expression of sAnk1 with SERCA1 leads to a reduction of the apparent Ca2+ affinity of SERCA1 but that the effect of sAnk1 is less than that of sarcolipin. The sAnk1 TM mutant has no effect on SERCA1 activity. Our results suggest that sAnk1 interacts with SERCA1 through its TM and cytoplasmic domains to regulate SERCA1 activity and modulate sequestration of Ca2+ in the sarcoplasmic reticulum lumen. The identification of sAnk1 as a novel regulator of SERCA1 has significant implications for muscle physiology and the development of therapeutic approaches to treat heart failure and muscular dystrophies linked to Ca2+ misregulation.
机译:小锚蛋白1(sAnk1)是一种17 kDa跨膜(TM)蛋白,可与细胞骨架蛋白obscurin结合,并稳定骨骼肌中的网络肌浆网。我们报告说sAnk1在其TM氨基酸序列中与肌钙蛋白(一种肌蛋白内质网Ca 2 + -ATPase(SERCA)的小蛋白抑制剂)具有同源性。在这里,我们调查sAnk1和SERCA1是否相互作用。我们的结果表明,sAnk1在从兔骨骼肌分离的肌质网囊泡中以及在转染以表达这些蛋白的COS7细胞中与SERCA1特异性相互作用。通过共免疫沉淀和基于各向异性的FRET方法证明了这种相互作用。通过诱变用亮氨酸取代sAnk1的所有TM氨基酸,结合减少了约2倍。这表明,与肌钙蛋白一样,sAnk1至少部分通过其TM结构域与SERCA1相互作用。 sAnk1的胞质域与SERCA1的结合也被检测到。 ATPase活性测定表明sAnk1与SERCA1的共表达导致SERCA1的表观Ca 2 + 亲和力降低,但sAnk1的作用小于肌钙蛋白。 sAnk1 TM突变体对SERCA1活性没有影响。我们的结果表明,sAnk1通过其TM和胞质域与SERCA1相互作用,以调节SERCA1活性并调节肌浆网腔内Ca 2 + 的螯合。 sAnk1作为SERCA1的新型调节剂的鉴定对肌肉生理学以及治疗与Ca 2 + 失调有关的心力衰竭和肌肉营养不良的治疗方法的发展具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号